The study showed a trend of improvement in anxiety, as the treatment group scored a mean of −1.41 on the ADAMS scale compared to the placebo group (−0.79), although the statistical result was not significant ( Table 1 ).
← all excerpts
Phenotypic Trade-Offs: Deciphering the Impact of Neurodiversity on Drug Development in Fragile X Syndrome.
1
—
—